Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
-2.1M
-
Total reported value, excl. options
-
$385M
-
Value change
-
-$47.9M
-
Number of buys
-
22
-
Number of sells
-
-27
-
Price
-
$28.09
Significant Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q4 2018
63 filings reported holding KNSA - Kiniksa Pharmaceuticals Intern - COM as of Q4 2018.
Kiniksa Pharmaceuticals Intern - COM (KNSA) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (3M shares), Hillhouse Capital Advisors, Ltd. (1.39M shares), ArrowMark Colorado Holdings LLC (1.24M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.13M shares), Sofinnova Investments, Inc. (923K shares), Vanguard Group Inc (908K shares), Cormorant Asset Management, LP (831K shares), BlackRock Inc. (645K shares), VHCP Management II, LLC (639K shares), and FMR LLC (639K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.